Please assess the completion status of the following clinical trial:

Trial Title: Subanesthetic IV Bolus Ketamine in the Treatment of Acute Depression

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. BSS greater than 4~2. BHS greater than 8~3. BDI greater than 19~4. Ability to give informed consent.~5. Active Duty military status.~6. Verified negative qualitative pregnancy test.~7. All participants must be accepted for psychiatric admission to the hospital PRIOR to consideration for enrollment in this study.~Exclusion Criteria:~1. Psychosis or Bipolar Disorder.~2. Pregnancy~3. Involuntary Status on presentation to the ED.~4. UDS positive for illicit drugs of abuse.~5. Blood Alcohol level greater than zero.~6. Previous enrollees in this treatment protocol will be excluded from repeat participation.~7. Any patient brought for command directed psychiatric evaluation.~8. Specific contraindications to the use of ketamine are as follows and under such circumstances or conditions, personnel with the following should be excluded from participation in this study:~   1. Patients with elevated intracranial pressure, uncontrolled hypertension, coronary artery disease, aneurysms, thyrotoxicosis, CHF, a recent history of head or eye injury, or angina.~  2. All personnel in whom a significant elevation of blood pressure would constitute a serious hazard to their overall health and well-being.~  3. Patients currently utilizing the following medications: conivaptan, Disatinib, peginterferon alfa-2b, quazepam, tocilizumab

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Normal Saline Infusion (Type: PLACEBO_COMPARATOR): A single IV bolus dose of normal saline solution.
- Subanesthetic IV Bolus Ketamine (Type: EXPERIMENTAL): a single sub-anesthetic rapid IV bolus dose of ketamine administered to acutely depressed patients with or without suicidality

Based on this trial design, predict the completion outcome and termination type (if applicable).